Highlights

Highlights from the Antiviral PK Workshop


Description

This online program summarizes the highlights of the 20th International Workshop on Clinical Pharmacology of HIV, Hepatitis and other Antiviral Drugs, which took place in Noordwijk, the Netherlands, 14-16 May 2019. It consists of two summary presentations given by Saye Khoo and Jennifer Kiser, and a written editorial by Dr. David Burger.

Needs Assessment

Optimal drug exposure is a key component of successful antiretroviral therapy. Understanding the clinical pharmacology of antiviral therapy is pivotal to designing optimal treatment and prevention strategies. Drug exposure is significantly influenced by patient medication-taking behaviour, drug-drug interactions and individual physiologic and genetic characteristics. These factors are central in determining therapeutic efficacy, failure or toxicity. Despite great progress, many pharmacological challenges still exist. Recently we have seen great advances in the pharmacological characteristics of antiretroviral agents – offering improved care to HIV-infected individuals. The Antiviral Pharmacology Workshop is one of the key forums where challenges and advances in HIV clinical pharmacology are discussed by the world’s top investigators and experts.

Learning Objectives

After participating in this program, you will be able to:
• Summarize the key data presented and discussed at the antiviral pharmacology workshop
• Describe how these findings can be translated into clinical practice to optimize routine patient management

Topics addressed in the presentations:
• Drug-drug interactions
• Pregnancy, TB, HBV, NASH
• New drug delivery systems

Modules
1 Jennifer Kiser discusses drug-drug interactions
2 Saye Khoo discusses pregnancy, new drugs and strategy, and other diseases (TB, HBV, NASH)
3 Saye Khoo, Jennifer Kiser and David Burger summarize take home messages and the future of antiviral PK
4 David Burger summarizes the workshop highlights in a written editorial

Faculty
Jennifer Kiser, PharmD, United States
Saye Khoo, MD, University of Liverpool, United Kingdom
David Burger, PharmD, PhD, the Netherlands

Time to complete
This activity consists of three video modules and a written editorial and will take ca. 1 hour to complete. We value your feedback - please take a few minutes to fill in the evaluation form in the end and receive your certificate of completion!

Support

Online publication of meeting highlights has been made possible by an unrestricted educational grant from ViiV Healthcare.

Content
  • Drug drug interactions, Jennifer Kiser, 20th Antiviral PK Workshop
  • Saye Khoo
  • Editorial, David Burger, 20th Antiviral PK Workshop
  • Take home messages and expert opinions
  • Survey PK Workshop
Completion rules
  • All units must be completed
  • Leads to a certification with a duration: Forever